396 related articles for article (PubMed ID: 31829527)
21. Psoriasis onset under dupilumab treatment in two patients affected by atopic dermatitis and one patient affected by alopecia areata: Clinical and dermoscopic patterns.
D'Ambra I; Babino G; Fulgione E; Calabrese G; Ronchi A; Alfano R; Argenziano G; Piccolo V
Dermatol Ther; 2020 Nov; 33(6):e14169. PubMed ID: 32779323
[No Abstract] [Full Text] [Related]
22. Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areata.
Tavoletti G; Chiei-Gallo A; Barei F; Marzano AV; Ferrucci SM
Int J Dermatol; 2024 Mar; 63(3):374-375. PubMed ID: 38197323
[No Abstract] [Full Text] [Related]
23. Alopecia Areata Related Paradoxical Reactions in Patients on Dupilumab Therapy: A Systematic Review.
Sachdeva M; Witol A; Mufti A; Maliyar K; Yeung J
J Cutan Med Surg; 2021; 25(4):451-452. PubMed ID: 33586473
[No Abstract] [Full Text] [Related]
24. Early onset of alopecia areata after dupilumab introduction in a patient with atopic dermatitis.
Barbarin C; Hosteing S; Nosbaum A; Allouchery M; Celerier P
Eur J Dermatol; 2019 Oct; 29(5):542-543. PubMed ID: 31789276
[No Abstract] [Full Text] [Related]
25. Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients.
Guttman-Yassky E; Renert-Yuval Y; Bares J; Chima M; Hawkes JE; Gilleaudeau P; Sullivan-Whalen M; Singer GK; Garcet S; Pavel AB; Lebwohl MG; Krueger JG
Allergy; 2022 Mar; 77(3):897-906. PubMed ID: 34460948
[TBL] [Abstract][Full Text] [Related]
26. Dual Efficacy of Upadacitinib in 2 Patients With Concomitant Severe Atopic Dermatitis and Alopecia Areata.
Gambardella A; Licata G; Calabrese G; De Rosa A; Alfano R; Argenziano G
Dermatitis; 2021 Oct; 32(1S):e85-e86. PubMed ID: 34405831
[No Abstract] [Full Text] [Related]
27. Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study.
Chiricozzi A; Balato A; Fabbrocini G; Di Nardo L; Babino G; Rossi M; Esposito M; Bertoldi AM; Girolomoni G; Gambardella A; Antonelli F; Patruno C; Fargnoli MC; Argenziano G; Peris K
J Am Acad Dermatol; 2023 Dec; 89(6):1251-1253. PubMed ID: 37169293
[No Abstract] [Full Text] [Related]
28. Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab.
Barroso-García B; Rial MJ; Molina A; Sastre J
J Investig Allergol Clin Immunol; 2018 Dec; 28(6):420-421. PubMed ID: 30530389
[No Abstract] [Full Text] [Related]
29. A case of atopic dermatitis-associated dupilumab-resistant alopecia totalis successfully treated with baricitinib.
Seo T; Izumi K; Kawamura T; Tsujiwaki M; Ujiie H
Dermatol Ther; 2022 Dec; 35(12):e15953. PubMed ID: 36269309
[No Abstract] [Full Text] [Related]
30. Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata.
Ito T; Kageyama R; Nakazawa S; Honda T
Exp Dermatol; 2020 Aug; 29(8):726-732. PubMed ID: 32533873
[TBL] [Abstract][Full Text] [Related]
31. Concurrent chronic alopecia areata and severe atopic dermatitis successfully treated with upadacitinib.
Asfour L; Getsos Colla T; Moussa A; Sinclair RD
Int J Dermatol; 2022 Nov; 61(11):e416-e417. PubMed ID: 35722925
[No Abstract] [Full Text] [Related]
32. Atopic dermatitis and multilocular alopecia areata simultaneously treated with baricitinib.
Pestana M; Brito Caldeira M; Duarte B
Actas Dermosifiliogr; 2024 Feb; 115(2):T200-T201. PubMed ID: 37952837
[No Abstract] [Full Text] [Related]
33. Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib.
Pestana M; Brito Caldeira M; Duarte B
Actas Dermosifiliogr; 2024 Feb; 115(2):200-201. PubMed ID: 36842474
[No Abstract] [Full Text] [Related]
34. Alopecia Universalis and Atopic Dermatitis Improvement with Dupilumab: Demonstration of a Shared Pathophysiology and Clinical Efficacy.
Dobkin H; Mullen R; Zirwas M
Skinmed; 2019; 17(2):139-140. PubMed ID: 31145072
[No Abstract] [Full Text] [Related]
35. Baricitinib improved alopecia areata concomitant with atopic dermatitis: A case report.
Uchida H; Kamata M; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol; 2021 Sep; 48(9):e472-e473. PubMed ID: 34151450
[No Abstract] [Full Text] [Related]
36. Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata.
Kageyama R; Ito T; Hanai S; Morishita N; Nakazawa S; Fujiyama T; Honda T; Tokura Y
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807704
[TBL] [Abstract][Full Text] [Related]
37. Development of alopecia areata-like reactions in a patient treated with dupilumab.
Yamane S; Nakagawa Y; Inui S; Fujimoto M
Allergol Int; 2022 Jul; 71(3):420-422. PubMed ID: 35346581
[No Abstract] [Full Text] [Related]
38. Selective JAK 1 inhibition with upadacitinib as a potential treatment for coexistent severe atopic dermatitis and alopecia areata.
Muzy G
An Bras Dermatol; 2024; 99(3):483-484. PubMed ID: 38403554
[No Abstract] [Full Text] [Related]
39. Prurigo-like atopic dermatitis in a child with CARD11-associated severe combined immunodeficiency successfully treated with dupilumab.
Gualdi G; Lougaris V; Amerio P; Petruzzellis A; Parodi A; Burlando M
Pediatr Dermatol; 2024; 41(1):158-159. PubMed ID: 37888582
[TBL] [Abstract][Full Text] [Related]
40. Case of alopecia areata during dupilumab treatment for atopic dermatitis.
Kanda N; Koto M; Hoashi T; Saeki H
J Dermatol; 2019 Sep; 46(9):e332-e333. PubMed ID: 30942915
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
